Globus Medical (GMED) Tops Q2 EPS by 2c

Globus Medical (NYSE: GMED) reported Q2 EPS of $0.32, $0.02 better than the analyst estimate of $0.30. Revenue for the quarter came in at $152.4 million versus the consensus estimate of $151.04 million.

For earnings history and earnings-related data on Globus Medical (GMED) click here.

You May Also Be Interested In

• Nvidia underperforms peers as report sparks rack delay worries
• ArcelorMittal (MT:NA) (MT) PT Raised to EUR65 at Jefferies
• Morgan Stanley Resumes Tapestry Inc. (TPR) at Overweight